Guideline: Breast Cancer Radiotherapy (Hungary): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| Line 23: | Line 23: | ||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | <span style="display:none">hasCancerType::C50: Breast cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | <span style="display:none">isPracticeGuideline</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
Revision as of 11:22, 6 December 2025
Go back to Hungary page
Primary purpose: To update the 2009 radiotherapy guidelines for breast cancer based on new scientific evidence, specifying recommendations for various stages and conditions of the disease.
Sponsor, manager or home institution: National Institute of Oncology.
Type of information: Latest scientific evidence to provide a comprehensive framework for the treatment of various stages and types of breast cancer. medical procedures, tumour staging. Click here to learn more.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
